Alternative Names
ANTI-CD4 MAB research-grade biosimilar; CEN 000029 research-grade biosimilar; CEN-000029 research-grade biosimilar; Centara research-grade biosimilar; CMT 412 research-grade biosimilar; CMT-412 research-grade biosimilar; MT 412 research-grade biosimilar; MT-412 research-grade biosimilar; Priliximab research-grade biosimilar; Priliximab (USAN/INN) research-grade biosimilar; CD4 antibody;T-cell surface glycoprotein CD4 antibody; T-cell surface antigen T4/Leu-3 antibody; CD antigen CD4 antibody
Immunogen
Recombinant Human CD4 protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.